European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Tenders

Insulin tenders in Germany

Insulin tenders in Germany: 19 listed on GranTender since 2024; 6 open now. Buyers with the most tenders: Deutsches Institut für Ernährungsforschung (7), Techniker Krankenkasse (5) and DAK-Gesundheit (4); suppliers with the most contract awards: Biocon Biologics Germany GmbH (3), Berlin-Chemie AG (1) and Lilly Deutschland GmbH (1). Sources: oeffentlichevergabe.de and TED. Data as of 18 November 2026; updated daily.

Tenders
19
Open tenders
6
Awards
7
Average bids per contract
3.6

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Open tenders

Latest tenders

TenderBuyerEstimated valueStatusPublished
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Insulin lispro, ATC A10AB04, A10AD04 f. d. Zeit 01.01.24 - 31.12.24 (zzgl. Verlängerungsoption 1x12 Monate)DAK-Gesundheit—Awarded12 January 2026
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Insulin lispro, ATC A10AB04 und A10AD04 für die Zeit 01.01.2026 - 31.12.2027DAK-Gesundheit—Open15 November 2025
Open-House-Biologika-Rabattverträge 2025-26 - Insulin lispro (ATC: A10AB04, Wirkstärke: 100 U/ml)Techniker Krankenkasse—Open9 September 2025
Mouse Ultrasensitive Insulin ELISA JumboDeutsches Institut für Ernährungsforschung—Closed4 August 2025
Insulin ELISADeutsches Institut für Ernährungsforschung—Closed22 July 2025
Mouse Ultrasensitive Insulin ELISA Jumbo PackDeutsches Institut für Ernährungsforschung—Closed17 July 2025
Open-House-Biologika-Rabattverträge 2025-18 - Insulin glargin (Wirkstärke: 100 U/ml)Techniker Krankenkasse—Open6 June 2025
Mouse Ultrasensitive Insulin ELISA JumboDeutsches Institut für Ernährungsforschung—Closed22 May 2025
1/DLII6/PM018 - Arzneimittel AntidiabetikaBundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der Bundeswehr—Awarded16 May 2025
Open House Biologika Rabattverträge 2025-13 - Insulin-isophan/Insulin, normal (human) (Wirkstoffkombination)Techniker Krankenkasse—Open8 May 2025
Open House Biologika Rabattverträge 2025-12 - Insulin-isophan (human)Techniker Krankenkasse—Open8 May 2025
Open House Biologika Rabattverträge 2025-11 - Insulin, normal (human)Techniker Krankenkasse—Open8 May 2025
Mouse Ultrasensitive Insulin ELISA Jumbo (Kopie)Deutsches Institut für Ernährungsforschung—Closed17 April 2025
Mouse Ultrasensitive Insulin ELISA JumboDeutsches Institut für Ernährungsforschung—Closed1 April 2025
Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V zum Wirkstoff Insulin glargin (Semglee)GWQ ServicePlus AG—Awarded22 January 2025
Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V zum Wirkstoff Insulin Aspart (Kirsty)GWQ ServicePlus AG—Awarded22 January 2025
Arzneimittelrahmenrabattvertrag gemäß § 130a Absatz 8 des Fünften Sozialgesetzbuchs - KIRSTY (Wirkstoff: Insulin aspart), ATC 10AB05DAK-Gesundheit—Awarded20 December 2024
Mouse Ultrasensitive Insulin ELISA Jumbo PackDeutsches Institut für Ernährungsforschung—Closed27 September 2024
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Insulin lispro, ATC A10AB04 und A10AD04 für die Zeit 01.01.2022 - 31.12.2023DAK-Gesundheit—Closed18 January 2024

Main CPV divisions

CPV codes of this topic

  • 33615000 Medicinal products used in diabetes

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Insulin and antidiabetic drugs in neighbouring countries

Today, 1 tender in the same niche is open in neighbouring countries.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Expected soon1

ExpectedBuyerWhatWhy we expect itConfidence
Dec 2026 – Jan 2027
every year
DAK-GesundheitInsulin and antidiabetic drugs
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Insulin lispro, ATC A10AB04, A10AD04 f. d. Zeit 01.01.24 - 31.12.24 (zzgl. Verlängerungsoption 1x12 Monate)
The buyer has published insulin tenders every year in January since 2024.
Earlier tenders: 01/2026, 12/2024, 01/2024
high

Forecast from public data, not an announcement. Methodology.

Insulin and antidiabetic drugs by city

Insulin and antidiabetic drugs in other countries

Insulin and antidiabetic drugs across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Which insulin tenders in Germany are open now?
6 of the 19 insulin tenders in Germany listed on GranTender are open for bids. For example: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Insulin lispro, AT…; Open-House-Biologika-Rabattverträge 2025-26 - Insulin lispro (ATC: A10AB04, Wirkstärke: 100 U/ml); Open-House-Biologika-Rabattverträge 2025-18 - Insulin glargin (Wirkstärke: 100 U/ml).
Where can I find insulin tenders in Germany?
GranTender lists them in one place, from oeffentlichevergabe.de and TED, with their buyers, winners and contract values; 6 are open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most insulin tenders in Germany?
By number of contracts won: Biocon Biologics Germany GmbH (3), Berlin-Chemie AG (1), Lilly Deutschland GmbH (1).
Which buyers publish the most insulin tenders in Germany?
By number of tenders: Deutsches Institut für Ernährungsforschung (7), Techniker Krankenkasse (5), DAK-Gesundheit (4).
Which CPV codes belong to “Insulin and antidiabetic drugs”?
33615000 Medicinal products used in diabetes; plus tenders without a usable CPV code whose title names the topic.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.